Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different nalmefene doses combined with hydromorphone for postoperative analgesia after colorectal cancer surgery
ChiCTR2000033520Phase 4Recruiting
- Sponsor
- Peking University Shougang Hospital
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalmefene and hydromorphone in postoperative pain (3 arms), sponsored by Peking University Shougang Hospital. Primary endpoint: Postoperative pain intensity. Started Jul 2020; status: recruiting.
02
Drugs
nalmefenehydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000033520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033520.